Sandra Leung Esq.
Net Worth

Last updated:

What is Sandra Leung Esq. net worth?

The estimated net worth of Ms. Sandra Leung Esq. is at least $101,331,442 as of 10 Mar 2024. She owns shares worth $16,434,005 as insider, has earned $27,327,437 from insider trading and has received compensation worth at least $57,570,000 in Bristol-Myers Squibb Company.

What is the salary of Sandra Leung Esq.?

Ms. Sandra Leung Esq. salary is $3,030,000 per year as Executive Vice President & Gen. Counsel in Bristol-Myers Squibb Company.

How old is Sandra Leung Esq.?

Ms. Sandra Leung Esq. is 64 years old, born in 1961.

What stocks does Sandra Leung Esq. currently own?

As insider, Ms. Sandra Leung Esq. owns shares in one company:

Company Title Shares Price per share Total value
Bristol-Myers Squibb Company (BMY) Executive Vice President & Gen. Counsel 339,967 $48.34 $16,434,005

What does Bristol-Myers Squibb Company do?

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

BMY logo
BMY
Bristol-Myers Squibb Company
$48.34

Sandra Leung Esq. insider trading

Bristol-Myers Squibb Company

Ms. Sandra Leung Esq. has made 9 insider trades between 2006-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 169,893 units of BMY stock on 28 Feb 2019. As of 10 Mar 2024 she still owns at least 339,967 units of BMY stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, $0.10 par value 5,789 N/A N/A
Option
Performance Shares 35,139 N/A N/A
Option
Common Stock, $0.10 par value 35,139 N/A N/A
Option
Market Share Units 5,789 N/A N/A
Option
Market Share Units 5,856 N/A N/A
Option
Common Stock, $0.10 par value 5,856 N/A N/A
Option
Common Stock, $0.10 par value 5,349 N/A N/A
Option
Market Share Units 5,856 N/A N/A
Option
Common Stock, $0.10 par value 34,726 N/A N/A
Option
Market Share Units 5,349 N/A N/A
Option
Market Share Units 5,787 N/A N/A
Option
Performance Shares 34,726 N/A N/A
Option
Market Share Units 6,272 N/A N/A
Option
Common Stock, $0.10 par value 6,272 N/A N/A
Option
Common Stock, $0.10 par value 5,787 N/A N/A
Option
Common Stock, $0.10 par value 5,856 N/A N/A
Option
Market Share Units 5,787 N/A N/A
Option
Common Stock, $0.10 par value 37,623 N/A N/A
Option
Performance Shares 75,246 N/A N/A
Option
Common Stock, $0.10 par value 5,856 N/A N/A
Option
Common Stock, $0.10 par value 5,787 N/A N/A
Option
Common Stock, $0.10 par value 6,270 N/A N/A
Option
Common Stock, $0.10 par value 4,737 N/A N/A
Option
Market Share Units 5,856 N/A N/A
Option
Market Share Units 6,270 N/A N/A
Sale
Common Stock, $0.10 par value 29,390 $68.04 $1,999,696
Sale
Common Stock, $0.10 par value 141,420 $63.24 $8,943,401
Option
Market Share Units 20,604 N/A N/A
Option
Market Share Units 20,604 N/A N/A
Option
Common Stock, $0.10 par value 51,598 N/A N/A
Option
Common Stock, $0.10 par value 51,598 N/A N/A
Option
Common Stock, $0.10 par value 51,598 N/A N/A
Option
Common Stock, $0.10 par value 45,170 N/A N/A
Option
Market Share Units 18,829 N/A N/A
Option
Market Share Units 18,829 N/A N/A
Option
Market Share Units 18,829 N/A N/A
Option
Option (right to buy) 169,893 $17.51 $2,974,826
Option
Common Stock, $0.10 par value 169,893 $17.51 $2,974,826
Option
Common Stock, $0.10 par value 68,896 N/A N/A
Option
Market Share Units 19,213 N/A N/A
Sale
Common Stock, $0.10 par value 156,582 $22.14 $3,466,725
Option
Common Stock, $0.10 par value 156,582 $22.14 $3,466,725
Option
Option (right to buy) 156,582 $22.14 $3,466,725
Option
Market Share Units 18,926 N/A N/A
Option
Common Stock, $0.10 par value 65,424 N/A N/A
Sale
Common Stock, $0.10 par value 92,405 $57.02 $5,268,563
Option
Common Stock, $0.10 par value 116,100 $27.01 $3,135,861
Option
Option (right to buy) 116,100 $27.01 $3,135,861
Option
Common Stock, $0.10 par value 100,000 $24.74 $2,474,000
Option
Option (right to buy) 100,000 $24.74 $2,474,000
Sale
Common Stock, $0.10 par value 72,544 $70.39 $5,106,372
Option
Market Share Units 14,492 N/A N/A
Option
Performance Shares 42,991 N/A N/A
Option
Common Stock, $0.10 par value 57,483 N/A N/A
Option
Common Stock, $0.10 par value 5,574 N/A N/A
Option
Market Share Units 5,574 N/A N/A
Option
Common Stock, $0.10 par value 14,560 $22.73 $330,949
Sale
Common Stock, $0.10 par value 10,152 $63.57 $645,342
Option
Option (right to buy) 14,560 $22.73 $330,949
Option
Common Stock, $0.10 par value 9,997 N/A N/A
Option
Market Share Units 9,997 N/A N/A
Option
Market Share Units 5,573 N/A N/A
Option
Common Stock, $0.10 par value 5,573 N/A N/A
Option
Common Stock, $0.10 par value 51,501 N/A N/A
Option
Market Share Units 7,418 N/A N/A
Sale
Common Stock, $0.10 par value 11,746 $60.39 $709,282
Option
Common Stock, $0.10 par value 15,000 $25.45 $381,750
Option
Option (right to buy) 15,000 $25.45 $381,750
Option
Market Share Units 4,878 N/A N/A
Option
Common Stock, $0.10 par value 4,878 N/A N/A
Option
Common Stock, $0.10 par value 5,573 N/A N/A
Option
Market Share Units 5,573 N/A N/A
Option
Restricted Stock Units 4,793 N/A N/A
Option
Market Share Units 7,418 N/A N/A
Option
Common Stock, $0.10 par value 99,937 N/A N/A
Option
Option (right to buy) 15,000 $28.11 $421,650
Sale
Common Stock, $0.10 par value 10,490 $54.28 $569,376
Option
Common Stock, $0.10 par value 15,000 $28.11 $421,650
Option
Common Stock, $0.10 par value 81,203 N/A N/A
Option
Market Share Units 20,346 N/A N/A
Option
Performance Shares 60,857 N/A N/A
Option
Common Stock, $0.10 par value 3,980 N/A N/A
Option
Restricted Stock Units 3,980 N/A N/A
Option
Restricted Stock Units 4,793 N/A N/A
Option
Common Stock, $0.10 par value 4,793 N/A N/A
Option
Common Stock, $0.10 par value 19,310 $23.14 $446,833
Sale
Common Stock, $0.10 par value 16,780 $36.87 $618,679
Option
Option (right to buy) 19,310 $23.14 $446,833
Option
Common Stock, $0.10 par value 53,389 N/A N/A
Option
Restricted Stock Units 3,400 N/A N/A
Option
Performance Shares 49,989 N/A N/A
Option
Common Stock, $0.10 par value 3,980 N/A N/A
Option
Restricted Stock Units 3,980 N/A N/A
Option
Common Stock, $0.10 par value 4,792 N/A N/A
Option
Restricted Stock Units 4,792 N/A N/A
Option
Common Stock, $0.10 par value 7,355 N/A N/A
Option
Market Share Units 7,355 N/A N/A
Option
Market Share Units 7,417 N/A N/A
Option
Common Stock, $0.10 par value 7,417 N/A N/A
Option
Restricted Stock Units 3,400 N/A N/A
Option
Common Stock, $0.10 par value 3,400 N/A N/A
Option
Common Stock, $0.10 par value 3,980 N/A N/A
Option
Restricted Stock Units 3,980 N/A N/A
Option
Common Stock, $0.10 par value 7,354 N/A N/A
Option
Market Share Units 7,354 N/A N/A
Option
Common Stock, $0.10 par value 76,455 N/A N/A
Option
Performance Shares 76,455 N/A N/A
Option
Restricted Stock Units 6,800 N/A N/A
Option
Common Stock, $0.10 par value 3,400 N/A N/A
Option
Common Stock, $0.10 par value 47,483 N/A N/A
Option
Performance Shares 47,483 N/A N/A
Option
Common Stock, $0.10 par value 2,828 $28.9 $81,729
Option
Option (right to buy) 2,828 $28.9 $81,729
Option
Option (right to buy) 2,755 $28.9 $79,620
Option
Common Stock, $0.10 par value 2,755 $28.9 $79,620
Option
Common Stock, $0.10 par value 1,729 $23.1 $39,940
Option
Common Stock, $0.10 par value 1,840 $20.74 $38,162
Option
Option (right to buy) 1,840 $20.74 $38,162

Bristol-Myers Squibb Company key executives

Bristol-Myers Squibb Company executives and other stock owners filed with the SEC: